hotspot -WSS

hotspot

author：hotspot 2025-10-01 21:34:58 - browse：69

Adam's take main illustration — Molly Ferguson/STAT

Shares of Apellis Pharmaceuticals are rebounding, driven by a growing belief among some investors that the serious safety issue that has derailed Syfovre, the company’s eye disease treatment, is receding.

Declaring the crisis over is premature, but that could change with more uneventful weeks. Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value.

Apellis shares rose 32% last week, with most of the gains coming Friday on heavy trading volume. The reason: There have been no new cases of retinal occlusive vasculitis, or ROV, reported in people receiving injections of Syfovre.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

WSS

Clinical trials giant ICON acquires HumanFirst

Pfizer highlights cancer drugs it thinks could reignite investor interest

RaDonda Vaught to speak at CommonSpirit event on patient safety

Scientists unlock the key to scar

FDA does about

Investigation reveals sickle cell patients pressured into sterilizations

focus

hotspot

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

Addressing health care workers' trauma can help fight burnout

Heart attack and stroke risk calculators need revising

Fentanyl is making it harder to start addiction treatment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How to fix the rural physician shortage in the U.S.

Walensky prepares to leave CDC — and Congress — behind

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Medical leaders decry Supreme Court decision on affirmative action

Addressing health care workers' trauma can help fight burnout

entertainment

Questions and answers about ramping up H5N1 bird flu vaccine

Obesity now affects over 1 billion people worldwide, study finds

Investigation reveals sickle cell patients pressured into sterilizations

UnitedHealth argues against case alleging wrongful AI care denials

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

ASCO eve: Let’s set the table for this year's meeting

Wikipedia

leisure time

explore

knowledge